Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer

We have previously shown that aberrant promoter methylation of ZNF331 is a potential biomarker for colorectal cancer detection with high sensitivity (71%) and specificity (98%). This finding was recently confirmed by others, and it was additionally suggested that promoter methylation of ZNF331 was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vedeld, Hege Marie, Nesbakken, Arild, Lothe, Ragnhild A., Lind, Guro E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975481/
https://www.ncbi.nlm.nih.gov/pubmed/29854011
http://dx.doi.org/10.1186/s13148-018-0503-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975481/
https://www.ncbi.nlm.nih.gov/pubmed/29854011
http://dx.doi.org/10.1186/s13148-018-0503-2

Ejemplares similares